Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies

Fig. 1

Mean HIT-6 sum scores over all patients, in the receptor group and the ligand group. Values are illustrated as mean ± standard error. o = statistically significant in the Friedman test (p < 0.05). * = statistically significant in post-hoc pairwise comparisons with Bonferroni correction (p < 0.05). V1 = time of last injection; V2 = 8 weeks after last injection; V3 = 16 weeks after the last injection

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us